Inactive Instrument

Other languages Nymox Pharmaceutical Corporation Nasdaq

Equities

CA67076P1027

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2023	Nymox Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Nymox Pharmaceutical Corporation Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nymox Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 15
Nymox Pharmaceutical Corporation Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH	23-09-25
Nymox Pharmaceutical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Nymox Pharmaceutical Corporation Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results	23-07-25
Nymox Pharmaceutical Corporation Appoints Patrick Doody as Vice President, General Counsel and Member of Board of Directors	23-07-12
Fed Outlook Weighs on Exchange-Traded Funds, Equity Futures Premarket Thursday	23-07-06
Nymox Pharmaceutical Receives Delisting Notice From Nasdaq	23-07-06
Nymox Pharmaceutical Corporation Announces Removal of Board of Directors	23-06-27
Nymox Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12
Nymox Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-02
Nymox Pharmaceutical Corporation Auditor Raises 'Going Concern' Doubt	23-05-01
Nymox Pharmaceutical Names Christopher Riley as CFO	23-03-21
Nymox Pharmaceutical Gets Nasdaq Extension to Comply With Listing Requirements; Shares Rise	23-03-15
Nymox Pharmaceutical Corporation Announces New Marketing Submission for Nymozarfex for BPH	22-12-05
Nymox Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-16
Nymox Pharmaceutical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15
Nymox Pharmaceutical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15
Nymox Pharmaceutical Says on Track With Business Plan Development; Shares Rise	22-07-15
Nymox Pharmaceutical Receives Deficiency Notice From NASDAQ Over Minimum Bid Price; Shares Fall Midday	22-07-14
Nymox Pharmaceutical Gets FDA Refusal to File Letter for Prostate Enlargement Treatment Application; Shares Fall	22-05-23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Nymox Pharmaceutical Corporation Nasdaq

Equities

CA67076P1027

Other languages

Filters